ADCs in Preclinical Development for the Treatment of B-cell Malignancies With the evolving clinical data demonstrating the feasibility of the ADC platform in hematologic malignancies, the ...

Factory-configured ADCs promise cost advantage and pin compatibility while reducing lead times from months to weeks.

Antibody-drug conjugates (ADCs) took centre stage at the European Society of Medical Oncology (ESMO) Congress in Madrid 20 th-24 th October, which was back at full capacity for the first time ...

Researchers uncover corneal changes in multiple myeloma patients treated with belantamab mafodotin, revealing potential ...

Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025 HDP-101 demonstrated complete response in one female patient from cohort 5 ...

Runes like Presence of Mind, Magical Footwear, and Legend: Alacrity are crucial for ADCs. Among all of the roles and classes in League, the Marksmen have the highest ceiling in terms of raw damage ...

Veraxa Biotech has entered a joint discovery partnership with OmniAb tp develop a bispecific antibody drug conjugate (bsADC) ...

Silanna’s factory-configurable ADC Plural platform delivers improvements in affordability and lead times compared to legacy ...

The new children's services chief is optimistic the Children's Wellbeing and Schools Bill will improve outcomes for young ...

Alphamab Oncology (stock code: 9966.HK) announced that the preclinical data on two novel bispecific antibody-drug conjugates (ADCs) JSKN021 and JSKN022 were presented as posters at the 2025 American ...

“Emerging therapies such as ADCs and bispecifics involve complex mechanisms of action, requiring a deeper understanding of the cancer biology driving patient responses. By integrating spatial ...